Skip to content

Author

Si-Min Feng

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

TACE-HAIC plus targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a systematic review and meta-analysis of TACE- and HAIC-based comparisons

Background Against the backdrop of targeted therapy and immune checkpoint inhibitors (ICIs), the additional benefit of combining TACE and HAIC remains uncertain in unresectable hepatocellular carcinoma (uHCC). We separately evaluated TACE-based and HAIC-based comparator strategies. Methods CNKI, the Cochrane Library, E...

Pei-Zhuo Li, Hao Li, Bo-Yuan Mei et al. · 0 citations
Review Open access Sep 2026

Post-translational modification in hepatocellular carcinoma resistance: molecular mechanisms and therapeutic targeting

This review systematically summarizes the molecular mechanisms and common pathways through which PTMs contribute to therapeutic resistance in liver cancer, explores PTM-mediated mechanism underlying tumor persistence and distant recurrence, andamines how PTM-targeted strategies may reverse resistance.

Si-Min Feng, Jie Hu, Xiao-Xi Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.